, ,
Presentations this author is a contributor to:
Long-Term Persistence with Denosumab and Bisphosphonates after Fracture and Its Association with Clinical Outcomes: A Population-Based Linked Cohort Study (#191)
1:30 PM
Mike Lin
ESA and NZSE Clinical Orals and Lightning Talks
Balancing efficacy and rebound risk: extending denosumab dosing intervals in low-risk patients (#388)
5:30 PM
Brenda Ta
Joint Poster Session